Baidu
map

SCI写作之方法

2018-04-11 MedSci MedSci原创

科研基金

SCI写作之方法






版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1649734, encodeId=ce0e1649e34bd, content=<a href='/topic/show?id=35fb160183f' target=_blank style='color:#2F92EE;'>#SCI写作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16018, encryptionId=35fb160183f, topicName=SCI写作)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ecf423907717, createdName=xlwang2699, createdTime=Thu Nov 29 10:13:00 CST 2018, time=2018-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1279602, encodeId=d9d012e96023d, content=<a href='/topic/show?id=ab1430e146e' target=_blank style='color:#2F92EE;'>#写作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30714, encryptionId=ab1430e146e, topicName=写作)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1777154, createdName=chenhongpeng, createdTime=Fri Apr 13 05:13:00 CST 2018, time=2018-04-13, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1649734, encodeId=ce0e1649e34bd, content=<a href='/topic/show?id=35fb160183f' target=_blank style='color:#2F92EE;'>#SCI写作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16018, encryptionId=35fb160183f, topicName=SCI写作)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ecf423907717, createdName=xlwang2699, createdTime=Thu Nov 29 10:13:00 CST 2018, time=2018-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1279602, encodeId=d9d012e96023d, content=<a href='/topic/show?id=ab1430e146e' target=_blank style='color:#2F92EE;'>#写作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30714, encryptionId=ab1430e146e, topicName=写作)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1777154, createdName=chenhongpeng, createdTime=Fri Apr 13 05:13:00 CST 2018, time=2018-04-13, status=1, ipAttribution=)]

相关资讯

目标期刊选择

目标期刊选择

SCI写作之结果

SCI写作之结果图1.RCT研究患者招募流程图 图2.基线资料表图3.疗效表格图4.安全性表格图5.患者招募流程图RCT研究的结局有主要终点和次要终点之分,研究终点有几种形式,见下表

研究基础与工作条件的展示

研究基础与工作条件的展示

审稿意见分析

审稿意见分析

SCI写作之题目与摘要

SCI写作之题目与摘要

SCI写作之讨论

SCI写作之讨论

Baidu
map
Baidu
map
Baidu
map